ArticleVaccines2022

Immunogenicity of SARS-CoV-2 BNT162b2 Vaccine in People with Diabetes: A Prospective Observational Study.

Eleni Papadokostaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.